The Role of Pharmaceutical R&D in Expanding the Gene Expression Analysis Market
Pharmaceutical research and development is a key driver of the Gene Expression Analysis Market. Gene expression profiling allows for identification of drug targets, biomarker discovery, and evaluation of patient-specific responses.
This integration in drug discovery pipelines improves efficiency, shortens development timelines, and ensures personalized treatment strategies. Consequently, pharma R&D investments significantly expand market opportunities.
Market Outlook: With a market size of USD 4.74 billion in 2024, the market is anticipated to reach USD 12.67 billion by 2034, recording a 10.32% CAGR.
1 View